Stock Report

Lupin launches Jeet, a Patient Support Program to raise awareness of Cardiovascular Disease among Patients

Posted On : 2023-08-16 17:26:01( TIMEZONE : IST )

Lupin launches Jeet, a Patient Support Program to raise awareness of Cardiovascular Disease among Patients

Global pharma major Lupin Limited (Lupin) announced the launch of Jeet, its patient support program dedicated to heart-health. The initiative launch coincides with India's 76th Independence Day, symbolizing freedom from disease-related stress and a journey towards a happier and healthier life. Jeet will be a trusted partner in cardiovascular care, offering a range of benefits including savings on medical costs, disease counselling, medication reminders and lifestyle support. Jeet can be accessible through the Play or App Store, as well as the website Individuals can also connect with Jeet via the toll-free number 1800 202 7757.

Jeet offers a comprehensive approach to enhancing the doctor-patient experience by raising awareness about cardiovascular ailments and associated co-morbid conditions. The program includes features designed to encourage healthier lifestyle choices and provides support and care for a healthy heart. Jeet ensures timely medication reminders and promotes daily health and wellness activities including interactions that resonate with patients. Key functionalities include:

Rewards: Jeet incentivizes the adoption of a healthier lifestyle and adherence to prescribed medications by allocating heartbeats for consistent, timely adherence.

Reminders: Jeet enables uploading prescriptions and task scheduling to generate timely alerts, ensuring medications are taken punctually and reducing the likelihood of missed doses.

Support: Jeet connects users with heart-health coaches, who offer insights into the disease, offer navigational support, and suggest lifestyle improvements.

Speaking on the launch, Rajeev Sibal, President India Region Formulations, Lupin said, "Technology holds the potential to enhance outcomes by increasing patients' awareness of their condition and possible lifestyle interventions. With Jeet, our primary focus is to offer patients comprehensive support services that enhance their journey in medication adherence, lifestyle adoption, and beyond. Our goal is to empower patients to embrace a healthier and happier life. Jeet is a testament to Lupin's unwavering commitment to patient-centricity and improving healthcare in India."

Shares of Lupin Limited was last trading in BSE at Rs. 1081.70 as compared to the previous close of Rs. 1076.95. The total number of shares traded during the day was 90529 in over 4824 trades.

The stock hit an intraday high of Rs. 1105.80 and intraday low of 1077.35. The net turnover during the day was Rs. 98894131.00.

Source : Equity Bulls


Lupin INE326A01037 PatientSupportProgram HeartHealth Jeet